Lv3
398 积分 2026-03-09 加入
DODII: Bayesian Dose Optimization Design for Randomized Phase II Trials
1天前
待确认
BOP2: Bayesian optimal design for phase II clinical trials with simple and complex endpoints
1天前
已完结
TITE-BOIN-ET: Time-to-event Bayesian optimal interval design to accelerate dose-finding based on both efficacy and toxicity outcomes
1天前
已完结
A robust two‐stage design identifying the optimal biological dose for phase I/II clinical trials
1天前
已完结
STEIN: A simple toxicity and efficacy interval design for seamless phase I/II clinical trials
2天前
已完结
BOIN‐ET: Bayesian optimal interval design for dose finding based on both efficacy and toxicity outcomes
2天前
已完结
Bayesian Dose‐Finding in Phase I/II Clinical Trials Using Toxicity and Efficacy Odds Ratios
2天前
已完结
Adaptive Dose Selection Using Efficacy-Toxicity Trade-Offs: Illustrations and Practical Considerations
2天前
已完结
Dose-finding based on efficacy-toxicity trade-offs
2天前
已完结
Statistical aspects of the analysis of data from retrospective studies of disease
3个月前
已完结
皖公网安备34019202002308
